127 related articles for article (PubMed ID: 26172900)
1. Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.
Osinusi A; Townsend K; Kottilil S
JAMA; 2015 Jul; 314(2):186-7. PubMed ID: 26172900
[No Abstract] [Full Text] [Related]
2. Drug-Drug Interactions in Patients Co-infected With HCV and HIV.
Nozaki Y; Yanase M; Masaki N
JAMA; 2015 Jul; 314(2):186. PubMed ID: 26172899
[No Abstract] [Full Text] [Related]
3. Are we hopefully very close to the end of HCV?
Tahan V
Turk J Gastroenterol; 2014 Apr; 25(2):230-1. PubMed ID: 25003693
[No Abstract] [Full Text] [Related]
4. Hepatitis C and HIV co-infection: closing the gaps.
Graham CS
JAMA; 2015 Mar 24-31; 313(12):1217-8. PubMed ID: 25705993
[No Abstract] [Full Text] [Related]
5. Therapy for hepatitis C--the costs of success.
Hoofnagle JH; Sherker AH
N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
[No Abstract] [Full Text] [Related]
6. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
[No Abstract] [Full Text] [Related]
7. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
[No Abstract] [Full Text] [Related]
8. Viral hepatitis: new hepatitis C therapies-a medical pick and mix.
Ray K
Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):329. PubMed ID: 24776807
[No Abstract] [Full Text] [Related]
9. New Indications for Harvoni.
Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
[No Abstract] [Full Text] [Related]
10. Assessing a broader user base for new HCV drug.
Sekkides O
Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
[No Abstract] [Full Text] [Related]
11. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Graf Einsiedel H; Christiansen H; Wiegand J
Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
[No Abstract] [Full Text] [Related]
12. [Hope for Cirrhosis Patients with Genotype 1 Hepatitis C Virus Who Failed the Previous Treatment].
Kwon JH
Korean J Gastroenterol; 2015 Aug; 66(2):131-3. PubMed ID: 26513826
[No Abstract] [Full Text] [Related]
13. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Naggie S; Cooper C; Saag M; Workowski K; Ruane P; Towner WJ; Marks K; Luetkemeyer A; Baden RP; Sax PE; Gane E; Santana-Bagur J; Stamm LM; Yang JC; German P; Dvory-Sobol H; Ni L; Pang PS; McHutchison JG; Stedman CA; Morales-Ramirez JO; Bräu N; Jayaweera D; Colson AE; Tebas P; Wong DK; Dieterich D; Sulkowski M;
N Engl J Med; 2015 Aug; 373(8):705-13. PubMed ID: 26196665
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Infection in ESKD Patients.
Ladino M; Roth D
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1735-1737. PubMed ID: 30065068
[No Abstract] [Full Text] [Related]
15. [Interferon free recovery for almost all patients].
Einecke D
MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
[No Abstract] [Full Text] [Related]
16. Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment.
Gentile I; Borgia G
Evid Based Med; 2014 Dec; 19(6):223-4. PubMed ID: 25028605
[No Abstract] [Full Text] [Related]
17. Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports.
Chamorro-de-Vega E; Gimenez-Manzorro A; Sanjurjo M;
Med Clin (Barc); 2018 Jul; 151(2):85-86. PubMed ID: 29295791
[No Abstract] [Full Text] [Related]
18. Two Antiviral Drugs Approved For Adolescents With HCV.
Aschenbrenner DS
Am J Nurs; 2017 Aug; 117(8):22. PubMed ID: 28749879
[No Abstract] [Full Text] [Related]
19. Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
Enomoto M; Tateishi C; Tsuruta D; Tamori A; Kawada N
Ann Intern Med; 2018 May; 168(9):678-680. PubMed ID: 29335738
[No Abstract] [Full Text] [Related]
20. Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
Parlati L; Sirmai L; Dupuy CA; Glotz D; Pol S
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):e18-e19. PubMed ID: 30293896
[No Abstract] [Full Text] [Related]
[Next] [New Search]